Clinical Trial Update: The Use of 5mg Finasteride Versus 200mg Spironolactone and Topical 5% Minoxidil in Treating Postmenopausal Female Androgenetic Alopecia [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating finasteride vs spironolactone and topical minoxidil for postmenopausal female androgenetic alopecia has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Androgenetic Alopecia
• Female Pattern Hair Loss

Drugs mentioned

• FINASTERIDE (FINASTERIDE)
• MINOXIDIL TOPICAL SOLUTION, 5% (MINOXIDIL SOLUTION)
• Spironolactone (spironolactone)

Snippet

Sponsor: University of Florida | Conditions: Female Androgenetic Alopecia | Phase 4 | Status: WITHDRAWN